Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Chief Executive Officer bought 5,300 shares at $3.61 ($19,133)
  6. 4 Open-market sale Director sold 36,967 shares at an average $3.51 ($129,814)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Chief Executive Officer bought 20,000 shares at an average $3.00 ($60,018)
  9. 4 Open-market sale Director sold 6,105 shares at $4.28 ($26,117)
  10. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.33 ($21,640)
  11. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.40 ($22,000)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $4.22 ($84,400)
  20. 4 Derivatives Options or other derivatives

Page 10 of 19 · 376 filings